{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:35:26Z","timestamp":1783748126539,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier","isbn-type":[{"value":"9780443133480","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.ircmb.2023.10.003","type":"book-chapter","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T14:24:33Z","timestamp":1707229473000},"page":"1-23","source":"Crossref","is-referenced-by-count":4,"title":["Inflammatory breast cancer: Epidemiologic data and therapeutic results"],"prefix":"10.1016","member":"78","reference":[{"issue":"1","key":"10.1016\/bs.ircmb.2023.10.003_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-020-05938-2","article-title":"Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database","volume":"185","author":"Abraham","year":"2021","journal-title":"Breast Cancer Research and Treatment"},{"issue":"10","key":"10.1016\/bs.ircmb.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1245\/s10434-021-10453-9","article-title":"Inflammatory breast cancer at the extremes of age","volume":"28","author":"Adesoye","year":"2021","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib3","unstructured":"ajcc_6thed_cancer_staging_manual_part1.pdf [Internet]. [cit\u00e9 2 sept 2023]. Disponible sur: \u3008https:\/\/www.facs.org\/media\/tauiudl3\/ajcc_6thed_cancer_staging_manual_part1.pdf\u3009."},{"key":"10.1016\/bs.ircmb.2023.10.003_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer (IBC)","volume":"22","author":"Anderson","year":"2005","journal-title":"Breast Disease"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib5","first-page":"359","article-title":"Epidemiological risk factors associated with inflammatory breast cancer subtypes","volume":"27","author":"Atkinson","year":"2016","journal-title":"Cancer Causes Control CCC"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10549-019-05193-0","article-title":"Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001\u20132015)","volume":"175","author":"Aurit","year":"2019","journal-title":"Breast Cancer Research and Treatment"},{"issue":"18","key":"10.1016\/bs.ircmb.2023.10.003_bib7","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1002\/cam4.4170","article-title":"Inflammatory breast cancer appearance at presentation is associated with overall survival","volume":"10","author":"Balema","year":"2021","journal-title":"Cancer Medicine"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib8","series-title":"American Joint Committee on Cancer","article-title":"Manual for staging of cancer","year":"1988"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016950","article-title":"High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes","volume":"6","author":"Bekhouche","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.ircmb.2023.10.003_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.gofs.2017.09.005","article-title":"[Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - The experience of a Moroccan hospital]","volume":"45","author":"Benbrahim","year":"2017","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie"},{"issue":"1 Suppl","key":"10.1016\/bs.ircmb.2023.10.003_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1097-0142(19950101)75:1+<257::AID-CNCR2820751311>3.0.CO;2-Y","article-title":"Breast cancer","volume":"75","author":"Berg","year":"1995","journal-title":"Cancer"},{"issue":"11 Suppl","key":"10.1016\/bs.ircmb.2023.10.003_bib12","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/cncr.25175","article-title":"Inflammatory breast cancer in Tunisia: Epidemiological and clinical trends","volume":"116","author":"Boussen","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib13","doi-asserted-by":"crossref","unstructured":"Bryant T., cd. Diseases of the breast. New York: Wood\u2019s Medical and Surgical Monographs, 1889:35\u2013322.","DOI":"10.1001\/jama.1889.04440050034019"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1006489100283","article-title":"Inflammatory breast cancer survival: The role of obesity and menopausal status at diagnosis","volume":"64","author":"Chang","year":"2000","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib15","unstructured":"Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988\u20132008) - PMC [Internet]. [cit\u00e9 2 sept 2023]. Disponible sur: \u3008https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3568481\/\u3009."},{"key":"10.1016\/bs.ircmb.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.breast.2018.09.003","article-title":"The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review","volume":"42","author":"Copson","year":"2018","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"4","key":"10.1016\/bs.ircmb.2023.10.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100220","article-title":"Metastatic inflammatory breast cancer: Survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)","volume":"6","author":"Dano","year":"2021","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/annonc\/mdq345","article-title":"International expert panel on inflammatory breast cancer: Consensus statement for standardized diagnosis and treatment","volume":"22","author":"Dawood","year":"2011","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"15","key":"10.1016\/bs.ircmb.2023.10.003_bib19","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.7150\/jca.31176","article-title":"Perspectives on inflammatory breast cancer (IBC) research, clinical management and community engagement from the Duke IBC Consortium","volume":"10","author":"Devi","year":"2019","journal-title":"Journal of Cancer"},{"issue":"6","key":"10.1016\/bs.ircmb.2023.10.003_bib20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Annals of Surgical Oncology"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/LJMS.LJMS_5_20","article-title":"Cancer in Western Part of Libya: Pattern and management (2003\u20132018)","volume":"4","author":"Elhamadi","year":"2020","journal-title":"Libyan Journal of Medical Sciences"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib22","unstructured":"EOD10Dig.3rd.pdf [Internet]. [cit\u00e9 2 sept 2023]. Disponible sur: \u3008https:\/\/seer.cancer.gov\/archive\/manuals\/EOD10Dig.3rd.pdf\u3009."},{"issue":"12","key":"10.1016\/bs.ircmb.2023.10.003_bib23","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"issue":"9","key":"10.1016\/bs.ircmb.2023.10.003_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204372","article-title":"Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center","volume":"13","author":"Fouad","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib25","unstructured":"Foundation IBC (IBC). Inflammatory Breast Cancer (IBC) Foundation. [cit\u00e9 2 sept 2023]. Inflammatory Breast Cancer (IBC) Foundation. Disponible sur: \u3008https:\/\/eraseibc.org\/\u3009."},{"issue":"1","key":"10.1016\/bs.ircmb.2023.10.003_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): A randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"The Lancet Oncology"},{"issue":"4","key":"10.1016\/bs.ircmb.2023.10.003_bib27","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1245\/s10434-020-09152-8","article-title":"The prognostic value of axillary staging following neoadjuvant chemotherapy in inflammatory breast cancer","volume":"28","author":"Grova","year":"2021","journal-title":"Annals of Surgical Oncology"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/BD-180357","article-title":"Evaluating the incidence of inflammatory breast cancer using in population- and hospital-based cancer registries in Casablanca, Morocco","volume":"38","author":"Gunden","year":"2019","journal-title":"Breast Disease"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/bcr788","article-title":"Pathology and genetics: Tumours of the breast and female genital organs. WHO Classification of Tumours series - volume IV. Lyon, France: IARC Press","volume":"6","author":"Hanby","year":"2004","journal-title":"Breast Cancer Research: BCR"},{"issue":"13","key":"10.1016\/bs.ircmb.2023.10.003_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1016\/bs.ircmb.2023.10.003_bib31","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/j.clbc.2017.10.003","article-title":"Influence of biologic subtype of inflammatory breast cancer on response to neoadjuvant therapy and cancer outcomes","volume":"18","author":"Hieken","year":"2018","journal-title":"Clinical Breast Cancer"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib32","unstructured":"Inflammatory Breast Cancer International Consortium|IBC-IC [Internet]. [cit\u00e9 2 sept 2023]. Inflammatory Breast Cancer International Consortium|IBC-IC. Disponible sur: \u3008https:\/\/ibcic.org\/\u3009."},{"issue":"1","key":"10.1016\/bs.ircmb.2023.10.003_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/BD-220034","article-title":"Prognostic factors in inflammatory breast cancer: A single-center study","volume":"41","author":"Kridis","year":"2022","journal-title":"Breast Disease"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.breast.2023.01.011","article-title":"Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer","volume":"69","author":"Kuhar","year":"2023","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdm480","article-title":"Inflammatory breast cancer in Tunisia in the era of multimodality therapy","volume":"19","author":"Labidi","year":"2008","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.breast.2005.08.018","article-title":"Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer?","volume":"15","author":"L\u00ea","year":"2006","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/BD-210014","article-title":"Recent advances in the epidemiology of inflammatory breast cancer","volume":"40","author":"Levine","year":"2021","journal-title":"Breast Disease"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib38","first-page":"E5","article-title":"Breast cancer in Tunisia in 2004: A comparative clinical and epidemiological study","volume":"95","author":"Maalej","year":"2008","journal-title":"Bulletin du Cancer (Paris)"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib39","first-page":"223","article-title":"Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results","volume":"10","author":"Manai","year":"2019","journal-title":"Molecular and Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib40","unstructured":"Masson E. EM-Consulte. [cit\u00e9 2 sept 2023]. Cancer du sein de la femme jeune: probl\u00e8mes et questions. Disponible sur: \u3008https:\/\/www.em-consulte.com\/article\/17239\u3009."},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/annonc\/mdt525","article-title":"Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes","volume":"25","author":"Masuda","year":"2014","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib42","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.7314\/APJCP.2015.16.3.1277","article-title":"Inflammatory breast cancer in Tunisia from 2005 to 2010: Epidemiologic and anatomoclinical transitions from published data","volume":"16","author":"Mejri","year":"2015","journal-title":"Asian Pacific Journal of Cancer Prevention APJCP"},{"issue":"12","key":"10.1016\/bs.ircmb.2023.10.003_bib43","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/1097-0142(19801215)46:12<2741::AID-CNCR2820461234>3.0.CO;2-W","article-title":"Epidemiologic features of rapidly progressing breast cancer in Tunisia","volume":"46","author":"Mourali","year":"1980","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/bs.ircmb.2023.10.003_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/07357909309018867","article-title":"Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer","volume":"11","author":"Mourali","year":"1993","journal-title":"Cancer Investigation"},{"issue":"7","key":"10.1016\/bs.ircmb.2023.10.003_bib45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/CAD.0000000000001310","article-title":"The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study","volume":"33","author":"\u00d6zdemir","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/bs.ircmb.2023.10.003_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145534","article-title":"Inflammatory breast cancer: A distinct clinicopathological entity transcending histological distinction","volume":"11","author":"Raghav","year":"2016","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/bs.ircmb.2023.10.003_bib47","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.3390\/cancers14163928","article-title":"Different prognostic values of tumour and nodal response to neoadjuvant chemotherapy depending on subtypes of inflammatory breast cancer, a 317 patient-study","volume":"14","author":"Rog\u00e9","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/bs.ircmb.2023.10.003_bib48","first-page":"87","article-title":"Treatment of inflammatory cancer of the breast. Combined chemotherapy and radiotherapy. Apropos of 270 women treated at the Institut Gustave-Roussy","volume":"76","author":"Rou\u00ebss\u00e9","year":"1989","journal-title":"Bulletin du Cancer (Paris)"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10549-020-05864-3","article-title":"Risk factors for inflammatory and non-inflammatory breast cancer in North Africa","volume":"184","author":"Schairer","year":"2020","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-020-05785-1","article-title":"Obesity and related conditions and risk of inflammatory breast cancer: A nested case-control study","volume":"183","author":"Schairer","year":"2020","journal-title":"Breast Cancer Research and Treatment"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10549-012-2133-2","article-title":"Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990\u20132008","volume":"134","author":"Schlichting","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib52","unstructured":"SEER [Internet]. [cit\u00e9 2 sept 2023]. SEER ICD-O-3 coding materials. Disponible sur: \u3008https:\/\/seer.cancer.gov\/icd-o-3\/index.html\u3009."},{"issue":"1","key":"10.1016\/bs.ircmb.2023.10.003_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12885-018-4634-9","article-title":"Outcome of inflammatory breast cancer in Moroccan patients: Clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO)","volume":"18","author":"Slaoui","year":"2018","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1016\/bs.ircmb.2023.10.003_bib54","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM200011233432118","article-title":"The breasts of \u201cNight\u201d: Michelangelo as oncologist","volume":"343","author":"Stark","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2022.07.001","article-title":"HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications","volume":"174","author":"Tarantino","year":"2022","journal-title":"European Journal of Cancer (Oxford, England)"},{"key":"10.1016\/bs.ircmb.2023.10.003_bib56","unstructured":"The IBC Network Foundation [Internet]. [cit\u00e9 2 sept 2023]. The IBC Network Foundation. Disponible sur: \u3008https:\/\/theibcnetwork.org\/\u3009."},{"key":"10.1016\/bs.ircmb.2023.10.003_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.breast.2020.08.006","article-title":"A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer","volume":"53","author":"Van Berckelaer","year":"2020","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"2","key":"10.1016\/bs.ircmb.2023.10.003_bib58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-017-4119-6","article-title":"Inflammatory breast cancer in the Netherlands; improved survival over the last decades","volume":"162","author":"van Uden","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"issue":"11","key":"10.1016\/bs.ircmb.2023.10.003_bib59","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.31336","article-title":"Development of CNS metastases and survival in patients with inflammatory breast cancer","volume":"124","author":"Uemura","year":"2018","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/bs.ircmb.2023.10.003_bib60","first-page":"321","article-title":"Population-based statistics for women diagnosed with inflammatory breast cancer (United States)","volume":"15","author":"Wingo","year":"2004","journal-title":"Cancer Causes Control CCC"}],"container-title":["International Review of Cell and Molecular Biology","Overview of Inflammatory Breast Cancer: Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644823001612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644823001612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T15:14:58Z","timestamp":1753715698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644823001612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443133480"],"references-count":60,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2023.10.003","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}